Plasminogen Activator Inhibitor 1 (SERPINE1) (Middle Region) Peptide
SERPINE1
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN983586
Aperçu rapide pour Plasminogen Activator Inhibitor 1 (SERPINE1) (Middle Region) Peptide (ABIN983586)
Antigène
PAI1 (SERPINE1)
(Plasminogen Activator Inhibitor 1 (SERPINE1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Séquence
- PFPDSSTHRR LFHKSDGSTV SVPMMAQTNK FNYTEFTTPD GHYYDILELP
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-SERPINE1 Antibody,. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PAI1 (SERPINE1) (Plasminogen Activator Inhibitor 1 (SERPINE1))
-
Sujet
-
SERPINE1 acts as 'bait' for tissue plasminogen activator, urokinase, and protein C. Its rapid interaction with TPA may function as a major control point in the regulation of fibrinolysis.
Alias Symbols: PAI, PAI-1, PAI1, PLANH1
Protein Interaction Partner: ACTN4,ELANE,F2,IGFBP5,KLK2,KRT18,LRP1,LRP1B,LRP2,MMP3,ORM1,PLAT,PLAU,PLG,SERPINE1,UBQLN4,VTN,F2,IGFBP5,LRP1,ORM1,PLAT,PLAU,PLG,SERPINE1,VTN
Protein Size: 402 -
Poids moléculaire
- 43 kDa
-
ID gène
- 5054
-
NCBI Accession
- NM_000602, NP_000593
-
UniProt
- P05121
Antigène
-
Vous êtes ici:
